Cargando…
Pembrolizumab in bacillus Calmette-Guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (KEYNOTE-057)
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555576/ https://www.ncbi.nlm.nih.gov/pubmed/34759534 http://dx.doi.org/10.4103/iju.iju_244_21 |
| _version_ | 1784592005520687104 |
|---|---|
| author | Kumar, Bhuwan |
| author_facet | Kumar, Bhuwan |
| author_sort | Kumar, Bhuwan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8555576 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85555762021-11-09 Pembrolizumab in bacillus Calmette-Guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (KEYNOTE-057) Kumar, Bhuwan Indian J Urol Uroscan Wolters Kluwer - Medknow 2021 2021-10-01 /pmc/articles/PMC8555576/ /pubmed/34759534 http://dx.doi.org/10.4103/iju.iju_244_21 Text en Copyright: © 2021 Indian Journal of Urology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Uroscan Kumar, Bhuwan Pembrolizumab in bacillus Calmette-Guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (KEYNOTE-057) |
| title | Pembrolizumab in bacillus Calmette-Guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (KEYNOTE-057) |
| title_full | Pembrolizumab in bacillus Calmette-Guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (KEYNOTE-057) |
| title_fullStr | Pembrolizumab in bacillus Calmette-Guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (KEYNOTE-057) |
| title_full_unstemmed | Pembrolizumab in bacillus Calmette-Guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (KEYNOTE-057) |
| title_short | Pembrolizumab in bacillus Calmette-Guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (KEYNOTE-057) |
| title_sort | pembrolizumab in bacillus calmette-guérin unresponsive nonmuscle-invasive bladder cancer; a difficult to treat disease (keynote-057) |
| topic | Uroscan |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555576/ https://www.ncbi.nlm.nih.gov/pubmed/34759534 http://dx.doi.org/10.4103/iju.iju_244_21 |
| work_keys_str_mv | AT kumarbhuwan pembrolizumabinbacilluscalmetteguerinunresponsivenonmuscleinvasivebladdercanceradifficulttotreatdiseasekeynote057 |